Analyst Ratings for Neurocrine Bio. (NBIX)
NBIX Rating Summary
NBIX Price Target Summary
- Highest: $242.00 (Citi)
- Lowest: $144.00 (BMO Capital)
- Average: $187.68
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$187.68 (+18.6%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$187.68 (+18.6%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/2/2026 | Goldman Sachs | Corinne Johnson | New Coverage | Buy (N/A) |
213.00 (N/A) |
161.00 (158.29) |
-1.68% | Details |
| 5/21/2026 | Bernstein SocGen Group | Jeffrey Walch | New Coverage | Outperform (N/A) |
221.00 (N/A) |
154.67 (158.29) |
2.34% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
